Analyst Quinn Bolton of Needham maintained a Buy rating on Silicon Laboratories (SLAB – Research Report), boosting the price target to $150.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Quinn Bolton has given his Buy rating due to a combination of factors impacting Silicon Laboratories. Firstly, the company reported results for the fourth quarter that met expectations and offered guidance for the first quarter of 2025 slightly above market predictions, indicating a positive outlook. Furthermore, growth is anticipated to continue steadily each quarter through 2025, independent of broader economic conditions.
Additionally, Silicon Labs is experiencing strong progress in its continuous glucose monitoring (CGM) and electronic shelf label (ESL) segments, with projections that the CGM business could contribute significantly to revenue in the coming 12-18 months. Moreover, the company is poised to tap into substantial opportunities in the smart metering sector, particularly with projects in India and Japan. Inventory management improvements and expected gains in gross margins also support the positive rating, as these factors suggest a robust financial trajectory for the company.
In another report released on January 22, KeyBanc also maintained a Buy rating on the stock with a $160.00 price target.

